SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Iris W. Liou, Management of End-stage Liver Disease, Medical Clinics of North America, 2014, 98, 1, 119

    CrossRef

  2. 2
    Narayan Dharel, Arun J. Sanyal, Refractory Ascites: How to Establish the Diagnosis and What Can Be Done?, Current Hepatology Reports, 2014, 13, 1, 50

    CrossRef

  3. You have free access to this content3
    Paolo Angeli, Current management of uncomplicated ascites, Clinical Liver Disease, 2013, 2, 3
  4. 4
    Fredric D. Gordon, Ascites, Clinics in Liver Disease, 2012, 16, 2, 285

    CrossRef

  5. 5
    P. Bellot, B. Martínez-Moreno, J.M. Palazón, J. Duch, Ascitis y síndrome hepatorrenal, Medicine - Programa de Formación Médica Continuada Acreditado, 2012, 11, 11, 644

    CrossRef

  6. 6
    Florence Wong, Management of ascites in cirrhosis, Journal of Gastroenterology and Hepatology, 2012, 27, 1
  7. 7
    David H. Ellison, Ewout J. Hoorn,, Christopher S. Wilcox, Brenner and Rector's The Kidney, 2011,

    CrossRef

  8. 8
    Young Seok Kim, Ascites, Hepatorenal Syndrome and Spontaneous Bacterial Peritonitis in Patients with Portal Hypertension, The Korean Journal of Gastroenterology, 2010, 56, 3, 168

    CrossRef

  9. 9
    EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis, Journal of Hepatology, 2010, 53, 3, 397

    CrossRef

  10. 10
    G. Nasr, A. Hassan, S. Ahmed, A. Serwah, Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites, Journal of Cardiovascular Disease Research, 2010, 1, 3, 136

    CrossRef

  11. 11
    Wei Hou, Arun J. Sanyal, Ascites: Diagnosis and Management, Medical Clinics of North America, 2009, 93, 4, 801

    CrossRef

  12. 12
    Guadalupe Garcia-Tsao, Joseph Lim, Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program, The American Journal of Gastroenterology, 2009, 104, 7, 1802

    CrossRef

  13. 13
    Bruce A. Runyon, Management of adult patients with ascites due to cirrhosis: An update, Hepatology, 2009, 49, 6
  14. 14
    Victor J. Navarro, Simona Rossi, Steven K. Herrine, Pharmacology and Therapeutics, 2009,

    CrossRef

  15. 15
    R. Gonzlez-Alonso, L. Crespo, X. Garca-Aguilera, A. Albillos Martnez, Ascitis y s?ndrome hepatorrenal en la cirrosis hep?tica, Medicine - Programa de Formaci?n M?dica Continuada Acreditado, 2008, 10, 11, 702

    CrossRef

  16. 16
    Pere Ginès, Florence Wong, Hugh Watson, Slobodan Milutinovic, Luis Ruiz del Arbol, Dan Olteanu, Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: A randomized trial, Hepatology, 2008, 48, 1
  17. 17
    David H. Ellison, Christopher S. Wilcox, Therapy in Nephrology & Hypertension, 2008,

    CrossRef

  18. 18
    Daniel Ackermann, David Mordasini, Lydie Cheval, Martine Imbert-Teboul, Bruno Vogt, Alain Doucet, Sodium retention and ascites formation in a cholestatic mice model: Role of aldosterone and mineralocorticoid receptor?, Hepatology, 2007, 46, 1
  19. 19
    Mitchell H. Rosner, Rohit Gupta, David Ellison, Mark D. Okusa, Management of cirrhotic ascites: Physiological basis of diuretic action, European Journal of Internal Medicine, 2006, 17, 1, 8

    CrossRef

  20. 20
    Genro Fujisawa, Shigeaki Muto, Koji Okada, Eiji Kusano, Shun Ishibashi, Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats, Translational Research, 2006, 148, 3, 149

    CrossRef

  21. 21
    Bimaljit Singh Sandhu, Arun J. Sanyal, Management of Ascites in Cirrhosis, Clinics in Liver Disease, 2005, 9, 4, 715

    CrossRef

  22. 22
    PRATIMA SHARMA, HUGO E. VARGAS, JORGE RAKELA, Transplantation of the Liver, 2005,

    CrossRef

  23. 23
    M. Gonzlez Garca, L. Ruiz del rbol Olmos, A. Albillos Martnez, Ascitis y s?ndrome hepatorrenal, Medicine - Programa de Formaci?n M?dica Continuada Acreditado, 2004, 9, 8, 504

    CrossRef

  24. 24
    Alexandre Pariente, Comment traiter une première poussée d’ascite ?, Gastroentérologie Clinique et Biologique, 2004, 28, 256

    CrossRef

  25. 25
    Xavier Amiot, Comment traiter une première poussée d’ascite ?, Gastroentérologie Clinique et Biologique, 2004, 28, 118

    CrossRef

  26. 26
    Bruce A. Runyon, Management of adult patients with ascites due to cirrhosis, Hepatology, 2004, 39, 3
  27. 27
    Jayanta Choudhury, Arun J. Sanyal, Treatment of ascites, Current Treatment Options in Gastroenterology, 2003, 6, 6, 481

    CrossRef

  28. 28
    Nelson Garcia, Arun J. Sanyal, Ascites, Current Treatment Options in Gastroenterology, 2001, 4, 6, 527

    CrossRef

  29. 29
    Guadalupe Garcia–Tsao, Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis, Gastroenterology, 2001, 120, 3, 726

    CrossRef

  30. 30
    Andy S. Yu, Ke-Qin Hu, MANAGEMENT OF ASCITES, Clinics in Liver Disease, 2001, 5, 2, 541

    CrossRef

  31. 31
    Angels Ginès, Ramon Planas, Paolo Angeli, Carlos Guarner, Francesco Salerno, Pere Ginès, Joan Saló, Nivardo Rodriguez, Eugeni Domènech, Germán Soriano, Luis Anibarro, Miguel Angel Gassull, Angelo Gatta, Vicente Arroyo, Juan Rodés, Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: Comparison with therapeutic paracentesis, Hepatology, 1995, 22, 1
  32. 32
    Pere Ginès, Andrés Cárdenas, Vicente Arroyo, Juan Rodés, Ascites, Hepatorenal Syndrome and Spontaneous Bacterial Peritonitis,